loader

World Tenders & Procurement Opportunities

687428- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient Sarilumab, ATC L04AC14

World Biggest Tenders Source

This tender with title 687428- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient Sarilumab, ATC L04AC14 has been published on Bidding Source portal dated 23 Oct 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

687428- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient Sarilumab, ATC L04AC14
Invitation for Bids
687428
Germany
23 Oct 2025
30 Sep 2027
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

689646- Germany – Pharmaceutical products – Open House Original Discount Agreements 2025-33 - Propranolol (Dosage Form: Oral Solution) Germany 690691- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the German Social Code (SGB V) through an open-house model for the active ingredient tocilizumab (WHO ATC code: L04AC07) Germany 688999- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the aforementioned active ingredients with the option of concluding the agreement within the framework of the so-called open house procedure. Germany 688518- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the aforementioned active ingredients with the option of concluding the agreement within the framework of the so-called open house procedure. Germany 691635- Germany – Pharmaceutical products – Open-House Biologics Discount Agreements 2025-25 - Aflibercept (ATC: S01LA05; Potency: 40 mg/ml) Germany 688929- Germany – Pharmaceutical products – Open framework agreement on pharmaceutical discounts pursuant to Section 130a Paragraph 8 SGB V with the option to join at any time, so-called approval model 2024-09 Germany 688614- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-08 - Denosumab Germany 689561-Awarded - Germany – Pharmaceutical products – Supply of contrast media to contracted radiologists in the areas of the KV Westfalen-Lippe and the KV Nordrhein Germany 687423- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an open-house model for the active ingredient pamidronic acid (ATC code according to WHO: M05BA03) Germany 686726- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the German Social Code (SGB V) through an open-house model for the active ingredient teriparatide (ATC code according to WHO: H05AA02) Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans